MC
TWST icon

Metavasi Capital’s Twist Bioscience TWST Stock Holding History

Metavasi Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1M Buy
176,004
+76,004
+76% +$4.95M 6.32% 6
2026
Q1 		$4.75M Buy
+100,000
New +$4.48M 1.72% 17

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Metavasi Capital's TWST Position: Q2 2026 in Review

Metavasi Capital increased its Twist Bioscience (TWST) stake by 76% in Q2 2026, buying an estimated $4.95M and bringing the position to 176,004 shares worth $18.1M. The position accounts for 6.32% of the portfolio, ranked #6.

Metavasi Capital first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Metavasi Capital held 176,004 shares of Twist Bioscience worth $18.1M as of Q2 2026.
  • Metavasi Capital bought 76,004 Twist Bioscience shares in Q2 2026, an estimated $4.95M.
  • Twist Bioscience made up 6.32% of Metavasi Capital's portfolio in Q2 2026, its #6 holding.
  • Metavasi Capital first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Metavasi Capital's 13F filing for Q2 2026, filed 14 Aug 2026.